Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+2.24M
-
Total reported value, excl. options
-
$178M
-
Value change
-
+$12.6M
-
Put/Call ratio
-
0.01
-
Number of buys
-
67
-
Number of sells
-
-27
-
Price
-
$5.49
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2023
108 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2023.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
of 44.7M outstanding shares and own 72.68% of the company stock.
Largest 10 shareholders include B. Riley Asset Management, LLC (3.06M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.86M shares), BlackRock Inc. (2.62M shares), Harvey Partners, LLC (2.52M shares), AMH Equity Ltd (2M shares), VANGUARD GROUP INC (1.96M shares), DIMENSIONAL FUND ADVISORS LP (1.82M shares), Granahan Investment Management, LLC (1.44M shares), ROYCE & ASSOCIATES LP (1.4M shares), and BOOTHBAY FUND MANAGEMENT, LLC (1.17M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.